Abbott
Ovarian, breast cancer tests launched
Published in Health Risk Factor Week, May 3rd, 2005
Developed by Fujirebio Diagnostics, Inc., (FDI), the Architect CA 125 II assay aids in monitoring patients with ovarian cancer while the Architect CA 15-3 test aids in monitoring stage II and stage III breast cancer. Both tests supply doctors with the critical information they need to determine how patients are responding to treatment.
"Providing laboratories with excellent precision and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
More Articles from Health Risk Factor Week
- American Social Health Association
Association reports nation is failing to curb spread of STDs in young people - Children's Hospital, Winnipeg
Research add new data to exercise body of knowledge - Merck & Co., Inc.
Investigational HPV vaccine reduced infection and disease in study - Natl. Development & Research Inst. Inc., New York
Puerto Rican crack users in Puerto Rico have riskier sex than those in New York - Aachen University of Technology
Differentiation of human preadipocytes in vitro optimized - Agilent Technologies, Inc.
Finnish researcher honored with award for new doping-control technology - More from this issue of Health Risk Factor Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
